Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows provided by operating activities:
Net income	$ 1,547	$ 2,265
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	164	170
Amortization of operating lease right-of-use assets	251	241
Stock based compensation	182	94
Change in deferred tax assets	(482)	26
Realized gain on sale of investment in iBio Stock	0	(56)
Unrealized loss on investment in iBio Stock	42	73
Other, Net	(6)	19
Changes in operating assets and liabilities:
Accounts receivable, net	309	970
Inventories	(1,426)	(3,815)
Other current assets	(313)	(240)
Security deposits and other assets	(9)	(25)
Accounts payable	835	1,758
Accrued expenses and other liabilities	(129)	(74)
Operating lease obligations	(252)	(242)
Net cash provided by operating activities	713	1,164
Cash flows from investing activities:
Purchase of property and equipment	(308)	(117)
Proceeds from sale of iBio Stock	0	96
Proceeds from sale of machinery and equipment	21	0
Net cash used in investing activities	(287)	(21)
Cash flows from financing activities:
Advances under revolving credit facility	28,574	28,579
Proceeds from exercise of employee stock options	7	7
Repayments of advances under revolving credit facility	(27,602)	(29,151)
Repayments under term note payables	(1,453)	(862)
Repayments under finance lease obligations	0	(75)
Net cash used in financing activities	(474)	(1,502)
Net decrease in cash	(48)	(359)
Cash at beginning of period	210	402
Cash at end of period	162	43
Interest paid	59	123
Income taxes paid	371	258
Amount owed on purchase of property and equipment	$ 2	$ 32